Clinical trial Recruiting at 1 site Interventional Ages 55 and up

Dyadic self-management with caregivers for older adults with diabetes and cognitive concerns

Official title: Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program: A Hybrid Effectiveness-implementation Study

Run by The Hong Kong Polytechnic University · NCT07496359 · Data updated 2026-11-12

This study tests whether adding caregiver support to a Chronic Disease Self-Management Program helps older adults with diabetes and mild cognitive impairment see better diabetes control and cognitive function.

More Diabetes trials

Quick facts

Study typeInterventional
Ages55 Years and up
SexAll
Enrollment309 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedApril 1, 2026
Main results expectedNovember 2026
Study endsDecember 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07496359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 55+ with diabetes (HbA1c ≥ 6.5%), subjective cognitive concerns confirmed by MOCA, and a primary caregiver who has actively cared for them for at least a year.

Probably not a fit

Patients without a willing or able caregiver, or those with dementia or terminal illness, may not benefit from this dyadic approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial examines a dyadic approach where older adults with diabetes and cognitive concerns participate in a 6-week CDSMP program with a primary caregiver. Participants attend weekly 2.5-hour sessions and provide feedback through interviews and surveys. The study also looks at how this intervention can be implemented in real-world settings. It compares the CDSMP with caregiver support to usual care in a single-country setting at the Hong Kong Polytechnic University. Eligible participants include people aged 55 or older with diabetes and subjective/confirmed cognitive concerns and a primary caregiver who has been involved for at least one year.

Why it matters

Potential benefit: If successful, the approach could improve diabetes self-management and cognitive outcomes and provide a feasible care-supported model for chronic disease management.

How similar studies have gone: Previous studies in caregiver-supported chronic disease programs have shown potential benefits, but this specific dyadic CDSMP approach in older adults with cognitive concerns is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals with DM aged \>= 55 years old;
* Recent glycosylated haemoglobin (HbA1c) level of 6.5% or above without change in diabetes medication within the last 3 months based on centre's records;
* Subjective cognitive decline (using SCDQ21) (separately reported by the patient and/or caregiver) and confirmed by MOCA (Chinese version) screened by the research nurses;
* Subjects with nominated primary caregivers will be recruited in the intervention group;
* For caregivers: they will be considered in the project if they have been the primary caregiver for the person for at least 1 year and are providing or involved in the patient's care on a daily basis.

Exclusion Criteria:

* Medical diagnoses of dementia;
* Those who have terminal illness;
* For caregivers: those who are temporary caregivers and have only provided/involved in care for less than a year.

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.